Obeticholic Acid – Bezafibrate Combination Granted Orphan Drug Designation for Primary Biliary Cholangitis (PBC)
In mid-May 2023, Pharmaceutical Technology reported that a new combination treatment had earned Orphan Drug designation. This combo? Obeticholic acid (OCA) and bezafibrate. Together, they represent a potential therapeutic…